Noah Byrd possesses extensive experience in regulatory affairs, currently serving as Vice President of Global Regulatory Affairs at United Therapeutics Corporation, following roles as Associate Vice President and Senior Director in the same department. Prior experience includes a position as Senior Regulatory Scientist at Cato Research and a postdoctoral fellowship in the Department of Pediatrics and Cell Biology at Duke University. Noah Byrd holds a PhD in Biology from Wesleyan University and a summa cum laude Bachelor's degree in Botany from the University of Tennessee, Knoxville.